{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:58:18Z","timestamp":1775080698880,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T00:00:00Z","timestamp":1413849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10555-014-9528-y","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T20:17:26Z","timestamp":1413836246000},"page":"1081-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["E-cadherin germline mutation carriers: clinical management and genetic implications"],"prefix":"10.1007","volume":"33","author":[{"given":"Giovanni","family":"Corso","sequence":"first","affiliation":[]},{"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Biffi","sequence":"additional","affiliation":[]},{"given":"Chiara","family":"Trentin","sequence":"additional","affiliation":[]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Feroce","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Serrano","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Cassano","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Annibale","sequence":"additional","affiliation":[]},{"given":"Soraia","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"De Lorenzi","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Ferrara","sequence":"additional","affiliation":[]},{"given":"Riccardo","family":"Piagnerelli","sequence":"additional","affiliation":[]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"issue":"12","key":"9528_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., Parkin, D. M., et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893\u20132917.","journal-title":"International Journal of Cancer"},{"key":"9528_CR2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/cncr.23650","volume":"113","author":"RM Cisco","year":"2008","unstructured":"Cisco, R. M., Ford, J., & Norton, J. A. (2008). Hereditary diffuse gastric cancer. Implications of genetic testing for screening and prophylactic surgery. Cancer, 113, 1850\u20131856.","journal-title":"Cancer"},{"issue":"6674","key":"9528_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","volume":"392","author":"P Guilford","year":"1998","unstructured":"Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., et al. (1998). E-cadherin germline mutations in familial gastric cancer. Nature, 392(6674), 402\u2013405.","journal-title":"Nature"},{"key":"9528_CR4","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","volume":"297","author":"P Kaurah","year":"2007","unstructured":"Kaurah, P., MacMillan, A., Boyd, N., et al. (2007). Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA, 297, 2360\u201372.","journal-title":"JAMA"},{"issue":"18","key":"9528_CR5","first-page":"4085","volume":"58","author":"SA Gayther","year":"1998","unstructured":"Gayther, S. A., Gorringer, K. L., Ramus, S. J., Huntsman, D., Roviello, F., Grehan, N., et al. (1998). Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Research, 58(18), 4085\u20134089.","journal-title":"Cancer Research"},{"key":"9528_CR6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PD Pharoah","year":"2001","unstructured":"Pharoah, P. D., Guilford, P., & Caldas, C. (2001). Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 121, 1348\u20131353.","journal-title":"Gastroenterology"},{"key":"9528_CR7","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJM200106213442504","volume":"344","author":"DG Huntsman","year":"2001","unstructured":"Huntsman, D. G., Carneiro, F., Lewis, F. R., MacLeod, P. M., Hayashi, A., Monaghan, K. G., et al. (2001). Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. New England Journal of Medicine, 344, 1904\u20131909.","journal-title":"New England Journal of Medicine"},{"key":"9528_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J","volume":"92","author":"YS Chun","year":"2001","unstructured":"Chun, Y. S., Lindor, N. M., Smyrk, T. C., Petersen, B. T., Burgart, L. J., Guilford, P. J., et al. (2001). Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer, 92, 181\u2013187.","journal-title":"Cancer"},{"key":"9528_CR9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1067\/msy.2001.117099","volume":"130","author":"FR Lewis","year":"2001","unstructured":"Lewis, F. R., Mellinger, J. D., Hayashi, A., Lorelli, D., Monaghan, K. G., Carneiro, F., et al. (2001). Prophylactic total gastrectomy for familial gastric cancer. Surgery, 130, 612\u2013617. discussion 617\u2013619.","journal-title":"Surgery"},{"issue":"4","key":"9528_CR10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jamcollsurg.2005.12.017","volume":"202","author":"EA Newman","year":"2006","unstructured":"Newman, E. A., & Mulholland, M. W. (2006). Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. Journal of the American College of Surgeons, 202(4), 612\u2013617.","journal-title":"Journal of the American College of Surgeons"},{"issue":"12","key":"9528_CR11","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23501","volume":"112","author":"HT Lynch","year":"2008","unstructured":"Lynch, H. T., Kaurah, P., Wirtzfeld, D., Rubinstein, W. S., Weissman, S., Lynch, J. F., et al. (2008). Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer, 112(12), 2655\u20132663.","journal-title":"Cancer"},{"issue":"7","key":"9528_CR12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jmedgenet-2012-101472","volume":"50","author":"PR Benusiglio","year":"2013","unstructured":"Benusiglio, P. R., Malka, D., Rouleau, E., De Pauw, A., Buecher, B., Nogu\u00e8s, C., et al. (2013). CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. Journal of Medical Genetics, 50(7), 486\u2013489.","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"9528_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/bjc.2013.792","volume":"110","author":"C Petridis","year":"2014","unstructured":"Petridis, C., Shinomiya, I., Kohut, K., Gorman, P., Caneppele, M., Shah, V., et al. (2014). Germline CDH1 mutations in bilateral lobular carcinoma in situ. British Journal of Cancer, 110(4), 1053\u20131057.","journal-title":"British Journal of Cancer"},{"key":"9528_CR14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-009-0471-z","volume":"16","author":"PC Hebbard","year":"2009","unstructured":"Hebbard, P. C., MacMillan, A., Huntsman, D., Kaurah, P., Carneiro, F., Wen, X., et al. (2009). Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Annals of Surgical Oncology, 16, 1890\u20131895.","journal-title":"Annals of Surgical Oncology"},{"key":"9528_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","volume":"47","author":"RC Fitzgerald","year":"2010","unstructured":"Fitzgerald, R. C., Hardwick, R., Huntsman, D., Carneiro, F., Guilford, P., Blair, V., Consortium, I. G. C. L., et al. (2010). Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. Journal of Medical Genetics, 47, 436\u2013444.","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"9528_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejca.2010.10.011","volume":"47","author":"G Corso","year":"2011","unstructured":"Corso, G., Pedrazzani, C., Pinheiro, H., Fernandes, E., Marrelli, D., Rinnovati, A., et al. (2011). E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. European Journal of Cancer, 47(4), 631\u2013639.","journal-title":"European Journal of Cancer"},{"key":"9528_CR17","first-page":"1","volume":"38","author":"NM Lindor","year":"2008","unstructured":"Lindor, N. M., McMaster, M. L., Lindor, C. J., & Green, M. H. (2008). Concise handbook of familial cancer susceptibility syndromes\u2014second edition. Journal of the National Cancer Institute Monographs, 38, 1\u201393.","journal-title":"Journal of the National Cancer Institute Monographs"},{"issue":"15","key":"9528_CR18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jnci\/87.15.1126","volume":"87","author":"A Schatzkin","year":"1995","unstructured":"Schatzkin, A., Goldstein, A., & Freedman, L. S. (1995). What does it mean to be a cancer gene carrier? Problems in establishing causality from the molecular genetics of cancer. Journal of the National Cancer Institute, 87(15), 1126\u20131130.","journal-title":"Journal of the National Cancer Institute"},{"key":"9528_CR19","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19930515)71:10<2926::AID-CNCR2820711007>3.0.CO;2-X","volume":"71","author":"PA Lauren","year":"1993","unstructured":"Lauren, P. A., & Nevalainen, T. J. (1993). Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer, 71, 2926\u20132929.","journal-title":"Cancer"},{"key":"9528_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1055-3207(02)00004-2","volume":"11","author":"W El-Rifai","year":"2002","unstructured":"El-Rifai, W., & Powell, S. M. (2002). Molecular and biologic basis of upper gastrointestinal malignancy. Gastric carcinoma. Surgical Oncology Clinics of North America, 11, 273\u2013291.","journal-title":"Surgical Oncology Clinics of North America"},{"issue":"2","key":"9528_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bpg.2009.02.003","volume":"23","author":"C Oliveira","year":"2009","unstructured":"Oliveira, C., Seruca, R., & Carneiro, F. (2009). Hereditary gastric cancer. Best Practice & Research Clinical Gastroenterology, 23(2), 147\u2013157.","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"7","key":"9528_CR22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jmg.2004.018275","volume":"41","author":"AR Brooks-Wilson","year":"2004","unstructured":"Brooks-Wilson, A. R., Kaurah, P., Suriano, G., et al. (2004). Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. Journal of Medical Genetics, 41(7), 508\u2013517.","journal-title":"Journal of Medical Genetics"},{"issue":"15","key":"9528_CR23","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1158\/1078-0432.CCR-05-0247","volume":"11","author":"G Suriano","year":"2005","unstructured":"Suriano, G., Yew, S., Ferreira, P., Senz, J., Kaurah, P., Ford, J. M., et al. (2005). Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clinical Cancer Research, 11(15), 5401\u20135409.","journal-title":"Clinical Cancer Research"},{"issue":"34","key":"9528_CR24","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","volume":"20","author":"JM Birch","year":"2001","unstructured":"Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G., Kelsey, A. M., Harris, M., et al. (2001). Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene, 20(34), 4621\u20134628.","journal-title":"Oncogene"},{"issue":"2","key":"9528_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10689-010-9410-1","volume":"10","author":"G Corso","year":"2011","unstructured":"Corso, G., Marrelli, D., & Roviello, F. (2011). Familial gastric cancer: update for practice management. Familial Cancer, 10(2), 391\u2013396.","journal-title":"Familial Cancer"},{"issue":"2","key":"9528_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.gastro.2009.10.051","volume":"138","author":"LG Capelle","year":"2010","unstructured":"Capelle, L. G., Van Grieken, N. C., Lingsma, H. F., Steyerberg, E. W., Klokman, W. J., Bruno, M. J., et al. (2010). Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology, 138(2), 487\u2013492.","journal-title":"Gastroenterology"},{"issue":"26","key":"9528_CR27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM194912292412601","volume":"241","author":"K Jeghers","year":"1949","unstructured":"Jeghers, K., McKusick, V. A., & Katz, K. H. (1949). Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. New England Journal of Medicine December, 241(26), 1031\u20131036.","journal-title":"New England Journal of Medicine December"},{"key":"9528_CR28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cgh.2005.12.003","volume":"4","author":"V Blair","year":"2006","unstructured":"Blair, V., Martin, I., Shaw, D., Winship, I., Kerr, D., Arnold, J., et al. (2006). Hereditary diffuse gastric cancer: diagnosis and management. Clinical Gastroenterology and Hepatology, 4, 262\u2013275.","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"9528_CR29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.26398","volume":"131","author":"I Kluijt","year":"2012","unstructured":"Kluijt, I., Siemerink, E. J., Ausems, M. G., et al. (2012). CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. International Journal of Cancer, 131(2), 367\u2013376.","journal-title":"International Journal of Cancer"},{"key":"9528_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren, P. (1965). The Two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathologica et Microbiologica Scandinavica, 64, 31\u201349.","journal-title":"Acta Pathologica et Microbiologica Scandinavica"},{"issue":"3","key":"9528_CR31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9","volume":"14","author":"PJ Guilford","year":"1999","unstructured":"Guilford, P. J., Hopkins, J. B., Grady, W. M., Markowitz, S. D., Willis, J., Lynch, H., et al. (1999). E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Human Mutation, 14(3), 249\u2013255.","journal-title":"Human Mutation"},{"issue":"2","key":"9528_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bpg.2009.02.003","volume":"23","author":"C Oliveira","year":"2009","unstructured":"Oliveira, C., Seruca, R., & Carneiro, F. (2009). Hereditary gastric cancer. Best Practice & Research Clinical Gastroenterology, 23(2), 147\u2013157.","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"3\u20134","key":"9528_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000113015","volume":"72","author":"F Roviello","year":"2007","unstructured":"Roviello, F., Corso, G., Pedrazzani, C., Marrelli, D., De Falco, G., Suriano, G., et al. (2007). High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology, 72(3\u20134), 243\u2013247.","journal-title":"Oncology"},{"issue":"9","key":"9528_CR34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","volume":"18","author":"C Oliveira","year":"2009","unstructured":"Oliveira, C., Senz, J., Kaurah, P., Pinheiro, H., Sanges, R., Haegert, A., et al. (2009). Germline CDH1 deletions in hereditary diffuse gastric cancer families. Human Molecular Genetics, 18(9), 1545\u20131555.","journal-title":"Human Molecular Genetics"},{"key":"9528_CR35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/B978-0-12-394311-8.00015-7","volume":"116","author":"C Oliveira","year":"2013","unstructured":"Oliveira, C., Pinheiro, H., Figueiredo, J., Seruca, R., & Carneiro, F. (2013). E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Progress in Molecular Biology and Translational Science, 116, 337\u2013359.","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"5","key":"9528_CR36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/ddg048","volume":"12","author":"G Suriano","year":"2003","unstructured":"Suriano, G., Oliveira, C., Ferreira, P., Machado, J. C., Bordin, M. C., De Wever, O., et al. (2003). Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human Molecular Genetics, 12(5), 575\u2013582.","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"9528_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/humu.9473","volume":"28","author":"H More","year":"2007","unstructured":"More, H., Humar, B., Weber, W., Ward, R., Christian, A., Lintott, C., et al. (2007). Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Human Mutation, 28(2), 203.","journal-title":"Human Mutation"},{"issue":"6","key":"9528_CR38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2003.022061","volume":"53","author":"RC Fitzgerald","year":"2004","unstructured":"Fitzgerald, R. C., & Caldas, C. (2004). Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut, 53(6), 775\u2013778.","journal-title":"Gut"},{"issue":"12","key":"9528_CR39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00109-006-0091-z","volume":"84","author":"G Suriano","year":"2006","unstructured":"Suriano, G., Seixas, S., Rocha, J., & Seruca, R. (2006). A model to infer the pathogenic significance of CDH1 germline missense variants. Journal of Molecular Medicine (Berlin), 84(12), 1023\u20131031.","journal-title":"Journal of Molecular Medicine (Berlin)"},{"issue":"3","key":"9528_CR40","doi-asserted-by":"crossref","first-page":"e33783","DOI":"10.1371\/journal.pone.0033783","volume":"7","author":"J Simoes-Correia","year":"2012","unstructured":"Simoes-Correia, J., Figueiredo, J., Lopes, R., Stricher, F., Oliveira, C., Serrano, L., et al. (2012). E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PloS One, 7(3), e33783.","journal-title":"PloS One"},{"issue":"3","key":"9528_CR41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2012.159","volume":"21","author":"J Figueiredo","year":"2013","unstructured":"Figueiredo, J., Soderberg, O., Simoes-Correia, J., Grannas, K., Suriano, G., Seruca, R., et al. (2013). The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. European Journal of Human Genetics, 21(3), 301\u2013309.","journal-title":"European Journal of Human Genetics"},{"issue":"36","key":"9528_CR42","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.onc.1206672","volume":"22","author":"G Suriano","year":"2003","unstructured":"Suriano, G., Mulholland, D., de Wever, O., et al. (2003). The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene, 22(36), 5716\u20135719.","journal-title":"Oncogene"},{"issue":"7","key":"9528_CR43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jmg.2004.018275","volume":"41","author":"AR Brooks-Wilson","year":"2004","unstructured":"Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Ferreira, P., Mateus, A. R., Bruyneel, E., et al. (2004). Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. Journal of Medical Genetics, 41(7), 508\u2013517.","journal-title":"Journal of Medical Genetics"},{"issue":"6","key":"9528_CR44","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1136\/jmg.2003.015594","volume":"41","author":"G Keller","year":"2004","unstructured":"Keller, G., Vogelsang, H., Becker, I., et al. (2004). Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. Journal of Medical Genetics, 41(6), e89.","journal-title":"Journal of Medical Genetics"},{"issue":"9","key":"9528_CR45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ejso.2007.03.001","volume":"33","author":"G Corso","year":"2007","unstructured":"Corso, G., Roviello, F., Paredes, J., Plaschke, S., Ott, K., Suriano, G., et al. (2007). Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. European Journal of Surgical Oncology, 33(9), 1061\u20131067.","journal-title":"European Journal of Surgical Oncology"},{"issue":"22","key":"9528_CR46","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1093\/hmg\/ddn249","volume":"17","author":"J Simoes-Correia","year":"2008","unstructured":"Simoes-Correia, J., Figueiredo, J., Oliveira, C., van Hengel, J., Seruca, R., van Roy, F., et al. (2008). Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Human Molecular Genetics, 17(22), 3566\u20133576.","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"9528_CR47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/dds497","volume":"22","author":"IP Vogelaar","year":"2013","unstructured":"Vogelaar, I. P., Figueiredo, J., van Rooij, I. A., Sim\u00f5es-Correia, J., van der Post, R. S., Melo, S., et al. (2013). Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Human Molecular Genetics, 22(5), 919\u2013926.","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"9528_CR48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10238-012-0184-7","volume":"13","author":"M Garziera","year":"2013","unstructured":"Garziera, M., De Re, V., Geremia, S., Seruca, R., Figueiredo, J., Melo, S., et al. (2013). A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clinical and Experimental Medicine, 13(2), 149\u2013157.","journal-title":"Clinical and Experimental Medicine"},{"issue":"30","key":"9528_CR49","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/sj.onc.1202790","volume":"18","author":"G Handschuh","year":"1999","unstructured":"Handschuh, G., Candidus, S., Luber, B., Reich, U., Schott, C., Oswald, S., et al. (1999). Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene, 18(30), 4301\u20134312.","journal-title":"Oncogene"},{"issue":"13","key":"9528_CR50","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/ddm113","volume":"16","author":"AR Mateus","year":"2007","unstructured":"Mateus, A. R., Seruca, R., Machado, J. C., Keller, G., Oliveira, M. J., Suriano, G., et al. (2007). EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Human Molecular Genetics, 16(13), 1639\u20131647.","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"9528_CR51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.yexcr.2009.02.020","volume":"315","author":"AR Mateus","year":"2009","unstructured":"Mateus, A. R., Simoes-Correia, J., Figueiredo, J., et al. (2009). E-cadherin mutations and cell motility: a genotype-phenotype correlation. Experimental Cell Research, 315(8), 1393\u20131402.","journal-title":"Experimental Cell Research"},{"issue":"22","key":"9528_CR52","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1093\/hmg\/ddg316","volume":"12","author":"G Suriano","year":"2003","unstructured":"Suriano, G., Oliveira, M. J., Huntsman, D., Heindl, S., Alves, C. C., Suriano, G., et al. (2003). E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Human Molecular Genetics, 12(22), 3007\u20133016.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"9528_CR53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexcr.2005.07.010","volume":"310","author":"P Ferreira","year":"2005","unstructured":"Ferreira, P., Oliveira, M. J., Beraldi, E., Mateus, A. R., Nakajima, T., Gleave, M., et al. (2005). Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Experimental Cell Research, 310(1), 99\u2013104.","journal-title":"Experimental Cell Research"},{"issue":"2","key":"9528_CR54","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/hmg\/ddr469","volume":"21","author":"AC Ferreira","year":"2012","unstructured":"Ferreira, A. C., Suriano, G., Mendes, N., Gomes, B., Wen, X., Carneiro, F., et al. (2012). E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Human Molecular Genetics, 21(2), 334\u2013343.","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"9528_CR55","doi-asserted-by":"crossref","first-page":"e23188","DOI":"10.1371\/journal.pone.0023188","volume":"6","author":"J Figueiredo","year":"2011","unstructured":"Figueiredo, J., Simoes-Correia, J., Soderberg, O., Suriano, G., & Seruca, R. (2011). ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PloS One, 6(8), e23188.","journal-title":"PloS One"},{"issue":"9","key":"9528_CR56","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1245\/s10434-011-1648-9","volume":"18","author":"Y Chen","year":"2001","unstructured":"Chen, Y., Kingham, K., Ford, J. M., Rosing, J., Van Dam, J., Jeffrey, R. B., et al. (2001). A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Annals of Surgical Oncology, 18(9), 2594\u20132598.","journal-title":"Annals of Surgical Oncology"},{"key":"9528_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-009-0531-x","volume":"13","author":"P Guilford","year":"2010","unstructured":"Guilford, P., Humar, B., & Blair, V. (2010). Hereditary diffuse gastric cancer: translation of CDH1 germline mutation into clinical practice. Gastric Cancer, 13, 1\u201310.","journal-title":"Gastric Cancer"},{"issue":"4","key":"9528_CR58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.20566","volume":"94","author":"F Roviello","year":"2006","unstructured":"Roviello, F., Rossi, S., Marrelli, D., Pedrazzani, C., Corso, G., Vindigni, C., et al. (2006). Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. Journal of Surgical Oncology, 94(4), 275\u2013280. discussion 274.","journal-title":"Journal of Surgical Oncology"},{"key":"9528_CR59","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2168.2002.02065.x","volume":"89","author":"Y Kitagawa","year":"2002","unstructured":"Kitagawa, Y., Fujii, H., Mukai, M., Kubota, T., Otani, Y., & Kitajima, M. (2002). Radio-guided sentinel node detection for gastric cancer. British Journal of Surgery, 89, 604\u2013608.","journal-title":"British Journal of Surgery"},{"key":"9528_CR60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1072-7515(02)01594-6","volume":"196","author":"H Hayashi","year":"2003","unstructured":"Hayashi, H., Ochiai, T., Mori, M., Karube, T., Suzuki, T., Gunji, Y., et al. (2003). Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. Journal of the American College of Surgery, 196, 68\u201374.","journal-title":"Journal of the American College of Surgery"},{"key":"9528_CR61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bjs.4512","volume":"91","author":"T Lenhert","year":"2004","unstructured":"Lenhert, T., & Buhl, K. (2004). Techniques of reconstruction after total gastrectomy for cancer. British Journal of Surgery, 91, 528\u2013539.","journal-title":"British Journal of Surgery"},{"key":"9528_CR62","first-page":"270","volume":"66","author":"D Sharma","year":"2004","unstructured":"Sharma, D. (2004). Choice of digestive tract reconstructive procedure following total gastrectomy: a critical reappraisal. Indian Journal of Surgery, 66, 270\u2013276.","journal-title":"Indian Journal of Surgery"},{"issue":"5","key":"9528_CR63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/SLA.0b013e318167748c","volume":"247","author":"M Fein","year":"2008","unstructured":"Fein, M., Fuchs, K. H., Thalheimer, A., Freys, S. M., Heimbucher, J., Thiede, A., et al. (2008). Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Annals of Surgery, 247(5), 759\u2013765.","journal-title":"Annals of Surgery"},{"key":"9528_CR64","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/SLA.0b013e318155a7a1","volume":"246","author":"CG Peyre","year":"2007","unstructured":"Peyre, C. G., DeMeester, S. R., Rizzetto, C., Bansal, N., Tang, A. L., Ayazi, S., et al. (2007). Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Annals of Surgery, 246, 665\u2013671.","journal-title":"Annals of Surgery"},{"issue":"6","key":"9528_CR65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.sle.0000191589.84485.4a","volume":"15","author":"S Usui","year":"2005","unstructured":"Usui, S., Yoshida, T., Ito, K., Hiranuma, S., Kudo, S. E., & Iwai, T. (2005). Laparoscopy-assisted total gastrectomy for early gastric cancer: comparison with conventional open total gastrectomy. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 15(6), 309\u2013314.","journal-title":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques"},{"issue":"5","key":"9528_CR66","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00464-011-2043-0","volume":"26","author":"HM Yoon","year":"2012","unstructured":"Yoon, H. M., Kim, Y. W., Lee, J. H., Ryu, K. W., Eom, B. W., Park, J. Y., et al. (2012). Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer. Surgical Endoscopy, 26(5), 1377\u20131381.","journal-title":"Surgical Endoscopy"},{"issue":"32","key":"9528_CR67","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3748\/wjg.v19.i32.5365","volume":"19","author":"K Chen","year":"2013","unstructured":"Chen, K., Xu, X. W., Zhang, R. C., Pan, Y., Wu, D., & Mou, Y. P. (2013). Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer. World Journal of Gastroenterology, 19(32), 5365\u20135376.","journal-title":"World Journal of Gastroenterology"},{"key":"9528_CR68","doi-asserted-by":"crossref","unstructured":"Worster, E., Liu, X., Richardson, S., Hardwick, R.H., Dwerryhouse, S., Caldas, C., et al. (2014). The impact of prophylactic total gastrectomy on health-related quality of life. A prospective cohort study. Ann Surg, Jan 13. [Epub ahead of print].","DOI":"10.1097\/SLA.0000000000000446"},{"issue":"1","key":"9528_CR69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.soc.2011.09.003","volume":"21","author":"VR Blair","year":"2012","unstructured":"Blair, V. R. (2012). Familial gastric cancer: genetics, diagnosis, and management. Surgical Oncology Clinics of North America, 21(1), 35\u201356.","journal-title":"Surgical Oncology Clinics of North America"},{"issue":"3","key":"9528_CR70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.2415","volume":"216","author":"ME Barber","year":"2008","unstructured":"Barber, M. E., Save, V., Carneiro, F., Dwerryhouse, S., Lao-Sirieix, P., Hardwick, R. H., et al. (2008). Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Journal of Pathology, 216(3), 286\u2013294.","journal-title":"Journal of Pathology"},{"key":"9528_CR71","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.2002.010447","volume":"53","author":"A Charlton","year":"2004","unstructured":"Charlton, A., Blair, V., Shaw, D., Parry, S., Guilford, P., & Martin, I. G. (2004). Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut, 53, 814\u2013820.","journal-title":"Gut"},{"key":"9528_CR72","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/path.1564","volume":"203","author":"F Carneiro","year":"2004","unstructured":"Carneiro, F., Huntsman, D. G., Smyrk, T. C., Owen, D. A., Seruca, R., Pharoah, P., et al. (2004). Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Journal of Pathology, 203, 681\u2013687.","journal-title":"Journal of Pathology"},{"key":"9528_CR73","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31815e7f1a","volume":"32","author":"WM Rogers","year":"2008","unstructured":"Rogers, W. M., Dobo, E., Norton, J. A., Van Dam, J., Jeffrey, R. B., Huntsman, D. G., et al. (2008). Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. American Journal of Surgical Pathology, 32, 799\u2013809.","journal-title":"American Journal of Surgical Pathology"},{"key":"9528_CR74","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e31826ca204","volume":"36","author":"H Fujita","year":"2012","unstructured":"Fujita, H., Lennerz, J. K., Chung, D. C., Patel, D., Deshpande, V., Yoon, S. S., et al. (2012). Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. American Journal of Surgical Pathology, 36, 1709\u20131717.","journal-title":"American Journal of Surgical Pathology"},{"key":"9528_CR75","author":"YC Lim","year":"2014","unstructured":"Lim, Y. C., di Pietro, M., O\u2019Donovan, M., Richardson, S., Debiram, I., Dwerryhouse, S., et al. (2014). Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Gastrointestinal Endoscopy. doi: 10.1016\/j.gie.2013.11.040 .","journal-title":"Gastrointestinal Endoscopy"},{"issue":"1","key":"9528_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1754-9485.12080","volume":"58","author":"AJ Porter","year":"2014","unstructured":"Porter, A. J., Evans, E. B., Foxcroft, L. M., Simpson, P. T., & Lakhani, S. R. (2014). Mammographic and ultrasound features of invasive lobular carcinoma of the breast. Journal of Medical Imaging and Radiation Oncology, 58(1), 1\u201310.","journal-title":"Journal of Medical Imaging and Radiation Oncology"},{"issue":"6","key":"9528_CR77","first-page":"1731","volume":"143","author":"R Moll","year":"1993","unstructured":"Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993). Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. American Journal of Pathology, 143(6), 1731\u20131742.","journal-title":"American Journal of Pathology"},{"issue":"4","key":"9528_CR78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00000658-199522240-00012","volume":"222","author":"TJ Yeatman","year":"1995","unstructured":"Yeatman, T. J., Cantor, A. B., Smith, T. J., Smith, S. K., Reintgen, D. S., Miller, M. S., et al. (1995). Tumor biology of infiltrating lobular carcinoma. Implications for management. Annals of Surgery, 222(4), 549\u2013561.","journal-title":"Annals of Surgery"},{"issue":"3","key":"9528_CR79","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1148\/radiology.185.3.1438749","volume":"185","author":"M Gal Le","year":"1992","unstructured":"Le Gal, M., Ollivier, L., Asselain, B., Meunier, M., Laurent, M., Vielh, P., et al. (1992). Mammographic features of 455 invasive lobular carcinomas. Radiology, 185(3), 705\u2013708.","journal-title":"Radiology"},{"issue":"2","key":"9528_CR80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2214\/AJR.07.3827","volume":"192","author":"RF Brem","year":"2009","unstructured":"Brem, R. F., Ioffe, M., Rapelyea, J. A., Yost, K. G., Weigert, J. M., Bertrand, M. L., et al. (2009). Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. American Journal of Roentgenology, 192(2), 379\u2013383.","journal-title":"American Journal of Roentgenology"},{"issue":"1","key":"9528_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-007-9528-5","volume":"107","author":"RM Mann","year":"2008","unstructured":"Mann, R. M., Hoogeveen, Y. L., Blickman, J. G., & Boetes, C. (2008). MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Research and Treatment, 107(1), 1\u201314.","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7","key":"9528_CR82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcu.20052","volume":"32","author":"VL Selinko","year":"2004","unstructured":"Selinko, V. L., Middleton, L. P., & Dempsey, P. J. (2004). Role of sonography in diagnosing and staging invasive lobular carcinoma. Journal of Clinical Ultrasound, 32(7), 323\u2013332.","journal-title":"Journal of Clinical Ultrasound"},{"issue":"1","key":"9528_CR83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiology.178.1.1984294","volume":"178","author":"DJ Hilleren","year":"1991","unstructured":"Hilleren, D. J., Andersson, I. T., Lindholm, K., & Linnell, F. S. (1991). Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology, 178(1), 149\u2013154.","journal-title":"Radiology"},{"issue":"1","key":"9528_CR84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00005-013-0251-0","volume":"62","author":"E Vlug","year":"2014","unstructured":"Vlug, E., Ercan, C., van der Wall, E., van Diest, P. J., & Derksen, P. W. (2014). Lobular breast cancer: pathology, biology, and options for clinical intervention. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 62(1), 7\u201321.","journal-title":"Archivum Immunologiae et Therapiae Experimentalis (Warsz)"},{"issue":"3","key":"9528_CR85","first-page":"232","volume":"17","author":"ZK Albayrak","year":"2011","unstructured":"Albayrak, Z. K., Onay, H. K., Karata\u011f, G. Y., Karata\u011f, G. Y., & Karata\u011f, O. (2011). Invasive lobular carcinoma of the breast: mammographic and sonographic evaluation. Diagnostic and Interventional Radiology, 17(3), 232\u2013238.","journal-title":"Diagnostic and Interventional Radiology"},{"issue":"5","key":"9528_CR86","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2214\/ajr.161.5.8273634","volume":"161","author":"KN Krecke","year":"1993","unstructured":"Krecke, K. N., & Gisvold, J. J. (1993). Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. American Journal of Roentgenology, 161(5), 957\u2013960.","journal-title":"American Journal of Roentgenology"},{"issue":"3","key":"9528_CR87","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2333031484","volume":"233","author":"WA Berg","year":"2004","unstructured":"Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004). Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology, 233(3), 830\u2013849.","journal-title":"Radiology"},{"issue":"5","key":"9528_CR88","doi-asserted-by":"crossref","first-page":"W765","DOI":"10.2214\/AJR.12.9742","volume":"201","author":"KN Jones","year":"2013","unstructured":"Jones, K. N., Magut, M., Henrichsen, T. L., Boughey, J. C., Reynolds, C., & Glazebrook, K. N. (2013). Pure lobular carcinoma of the breast presenting as a hyperechoic mass: incidence and imaging characteristics. American Journal of Roentgenology, 201(5), W765\u2013769.","journal-title":"American Journal of Roentgenology"},{"issue":"3","key":"9528_CR89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/ejso.2001.1236","volume":"28","author":"SM Tan","year":"2002","unstructured":"Tan, S. M., Behranwala, K. A., Trott, P. A., Nasiri, N. A., Moskovic, E., Brown, G., et al. (2002). A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma. European Journal of Surgical Oncology, 28(3), 203\u2013208.","journal-title":"European Journal of Surgical Oncology"},{"issue":"2","key":"9528_CR90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ultrasmedbio.2004.11.005","volume":"31","author":"DO Watermann","year":"2005","unstructured":"Watermann, D. O., Tempfer, C., Hefler, L. A., Parat, C., & Stickeler, E. (2005). Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer. Ultrasound in Medicine and Biology, 31(2), 167\u2013174.","journal-title":"Ultrasound in Medicine and Biology"},{"issue":"3","key":"9528_CR91","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00330-013-3012-x","volume":"24","author":"J Lei","year":"2014","unstructured":"Lei, J., Yang, P., Zhang, L., Wang, Y., & Yang, K. (2014). Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. European Radiology, 24(3), 595\u2013602.","journal-title":"European Radiology"},{"issue":"3","key":"9528_CR92","first-page":"1219","volume":"34","author":"G Mariscotti","year":"2014","unstructured":"Mariscotti, G., Houssami, N., Durando, M., Bergamasco, L., Campanino, P. P., Ruggieri, C., et al. (2014). Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer. Anticancer Research, 34(3), 1219\u20131225.","journal-title":"Anticancer Research"},{"issue":"2","key":"9528_CR93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13244-014-0324-6","volume":"5","author":"TM Oliveira","year":"2014","unstructured":"Oliveira, T. M., Elias, J., Jr., Melo, A. F., Teixeira, S. R., Filho, S. C., Gon\u00e7alves, L. M., et al. (2014). Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods. Insights Imaging, 5(2), 183\u2013194.","journal-title":"Insights Imaging"},{"issue":"1","key":"9528_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.crad.2013.07.016","volume":"69","author":"M Muttalib","year":"2014","unstructured":"Muttalib, M., Ibrahem, R., Khashan, A. S., & Hajaj, M. (2014). Prospective MRI assessment for invasive lobular breast cancer. Correlation with tumour size at histopathology and influence on surgical management. Clinical Radiology, 69(1), 23\u201328.","journal-title":"Clinical Radiology"},{"issue":"8","key":"9528_CR95","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli, F., Boetes, C., Borisch, B., Decker, T., Federico, M., Gilbert, F. J., et al. (2010). Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. European Journal of Cancer, 46(8), 1296\u20131316.","journal-title":"European Journal of Cancer"},{"key":"9528_CR96","unstructured":"NHS National Institute for Health and Clinical Excellence. NICE clinical guideline 80. Early and locally advanced breast cancer: diagnosis and treatment. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG80NICEGuideline.pdf ."},{"key":"9528_CR97","doi-asserted-by":"crossref","unstructured":"Stuckey, A., Febbraro, T., Laprise, J., Wilbur, J.S., Lopes, V., Robison, K. (2014). Adherence patterns to national comprehensive cancer network guidelines for referral of women with breast cancer to genetics professionals. Am J Clin Oncol, Apr 5. [Epub ahead of print].","DOI":"10.1097\/COC.0000000000000073"},{"issue":"11A","key":"9528_CR98","first-page":"30","volume":"12","author":"RJ Winn","year":"1998","unstructured":"Winn, R. J., Botnick, W. Z., & Brown, N. H. (1998). The NCCN guideline program\u20131998. Oncology (Williston Park), 12(11A), 30\u201334.","journal-title":"Oncology (Williston Park)"},{"key":"9528_CR99","first-page":"11","volume":"59","author":"L Cataliotti","year":"2010","unstructured":"Cataliotti, L., Galimberti, V., & Mano, M. P. (2010). The nipple sparing mastectomy (NSM). Attualit\u00e0 in Senologia, 59, 11\u201320.","journal-title":"Attualit\u00e0 in Senologia"},{"issue":"1","key":"9528_CR100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PRS.0b013e3181f9589a","volume":"127","author":"DL Larson","year":"2011","unstructured":"Larson, D. L., Basir, Z., & Bruce, T. (2011). Is oncologic safety compatible with a predictably viable mastectomy skin flap? Plastic and Reconstructive Surgery, 127(1), 27\u201333.","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"12","key":"9528_CR101","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nrclinonc.2011.159","volume":"8","author":"JY Petit","year":"2011","unstructured":"Petit, J. Y., Veronesi, U., Lohsiriwat, V., Rey, P., Curigliano, G., Martella, S., et al. (2011). Nipple-sparing mastectomy\u2014is it worth the risk? Nature Reviews. Clinical Oncology, 8(12), 742\u2013747. 25.","journal-title":"Nature Reviews. Clinical Oncology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-014-9528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9528-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:07:21Z","timestamp":1565953641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-014-9528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9528"],"URL":"https:\/\/doi.org\/10.1007\/s10555-014-9528-y","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]}}}